Form 4: Viatris Inc. Director Malik Rajiv Reports Acquisition of Restricted Stock Units

Director Malik Rajiv reports acquisition of 23,660 restricted stock units (RSUs) in Viatris Inc. following his transition to a non-employee director role.

Summary

• Rajiv Malik, a director of Viatris Inc., reported the acquisition of 23,660 restricted stock units (RSUs) on March 6, 2025.
• The RSUs were granted as part of Viatris' non-employee director compensation program, following Malik's retirement from his executive role on April 1, 2024.
• Each RSU represents the right to receive one share of Viatris common stock and will vest on March 6, 2026.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs to Malik aligns his interests with those of shareholders as he continues to serve as a director.
• The vesting period of the RSUs on March 6, 2026, encourages long-term commitment to the company's success.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting date of the RSUs.

Management Comments

• Rajiv Malik informed Viatris of his intention to retire from his executive role and remain a member of the Board of Directors.

Industry Context

Granting stock-based compensation to non-employee directors is a common practice in the pharmaceutical industry to align their interests with shareholders and incentivize their contributions to the company's governance and strategic direction.

Comparison to Industry Standards

• Companies like Pfizer, Merck, and Johnson & Johnson also utilize stock-based compensation for their non-employee directors.
• The amount of RSUs granted to Malik appears consistent with standard compensation packages for directors in similarly sized pharmaceutical companies, though a full comparison would require access to detailed compensation data for Viatris' peers.
• The vesting schedule of the RSUs is also typical, aligning with industry norms for long-term incentive plans.

Management Changes

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the director's interests with those of shareholders.
• Employees: The transition of Malik to a non-executive role may have indirect impacts on organizational structure and leadership dynamics.

Key Dates